News Trends, News Analysis, News Archive.



Related Articles

companyNews reuters.com

UPDATE 1-Pfizer's Xeljanz gets FDA nod as joint disease treatment

Dec 14 (Reuters) - U.S. drugmaker Pfizer Inc said on Thursday the U.S. Food and Drug Administration (FDA) approved two doses of its drug Xeljanz for treatment of a joint disease.

businessNews reuters.com

Asian shares edge up, on track for weekly gain

TOKYO (Reuters) - Asian shares edged higher on Friday, on track for weekly gains, though sentiment was kept in check by Wall Street's weakness on concerns about the progress of U.S. tax reform.

companyNews reuters.com

GLOBAL MARKETS-Asian shares edge up, on track for weekly gain

TOKYO, Dec 15 (Reuters) - Asian shares edged higher on Friday, on track for weekly gains, though sentiment was kept in check by Wall Street's weakness on concerns about the progress of U.S. tax reform.

companyNews reuters.com

Pfizer's Xeljanz gets FDA nod as joint disease treatment

Dec 14 (Reuters) - U.S. drugmaker Pfizer Inc said on Thursday the United States Food and Drug Administration (FDA) approved two doses of its drug Xeljanz for the treatment of a joint disease.

companyNews reuters.com

BRIEF-Pfizer Announces FDA Approval Of Xeljanz® And Xeljanz® Xr For Treatment Of Active Psoriatic Arthritis

* PFIZER ANNOUNCES FDA APPROVAL OF XELJANZ® (TOFACITINIB) AND XELJANZ® XR FOR THE TREATMENT OF ACTIVE PSORIATIC ARTHRITIS

companyNews reuters.com

UPDATE 3-Oracle shares tumble as cloud outlook darkens

Dec 14 (Reuters) - Oracle Corp on Thursday forecast current-quarter cloud revenue growth that missed Street expectations after reporting disappointing second-quarter sales in the same business, sending its shares down nearly 7 percent after hours.

healthNews reuters.com

Families of dementia patients see positive effect of social robot seal

(Reuters Health) - Paro, a robotic baby harp seal, seems to improve dementia patients’ mood and increase opportunities for communication with family members, according to a small study.

healthNews reuters.com

Merck's Keytruda fails pivotal gastric cancer trial

(Reuters) - Merck & Co Inc said on Thursday a key late-stage trial testing Keytruda failed to meet its main goal of extending the lives of patients with a type of gastric cancer.

healthNews reuters.com

Childhood obesity climbing with media use, European doctors warn

(Reuters Health) - Children’s waistlines have been expanding in lock step with the amount of time they spend with televisions, computers, smartphones and tablets, European doctors say.

domesticNews reuters.com

Nephews of Venezuela's first lady sentenced to 18 years in U.S. drug case

(Reuters) - Two nephews of Venezuela’s first lady were sentenced to 18 years in prison on Thursday following their convictions in New York on drug trafficking charges.

healthNews reuters.com

Social media may help chronically ill connect to doctors, fellow patients

(Reuters Health) - Social media groups that bring together patients, family, friends and healthcare providers can improve patients’ outlook and reduce their anxiety and depression, a recent U.S. study suggests.

healthNews reuters.com

U.S. less generous than European nations with development assistance

(Reuters Health) - The U.S. contributes more than any other nation in development assistance for health to low- and middle-income countries, but its generosity falls short when compared in terms of size and wealth, a new study found.

healthNews reuters.com

Perrigo lines up bid for Merck's consumer health unit: sources

LONDON/FRANKFURT (Reuters) - Generic drugmaker Perrigo has decided to enter the fray for Merck KGaA's consumer health unit, sources told Reuters, and is preparing an indicative offer for the $4.7 billion business ahead of a deadline on Friday.

healthNews reuters.com

Transgender women may get small breasts with hormones

(Reuters Health) - Transgender women who take sex hormones to feminize their bodies may not experience as much breast development as they expect, a new European study suggests.

companyNews reuters.com

GLOBAL MARKETS-Global shares little changed after central bank meetings

* U.S. stocks down (Updates to Europe close, adds commentary)

healthNews reuters.com

Germany's Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the U.S. market, hoping for blockbuster sales despite regulators' concerns about side effects having frustrated its ambitions almost seven years ago.

healthNews reuters.com

Brain cells develop more mutations as we age

(Reuters Health) - Brain cells - neurons - develop gene mutations over the course of a lifetime, contributing to normal aging and potentially presenting a target for treatments that stave off dementia and other types of cognitive decline, researchers say.

companyNews reuters.com

UPDATE 2-European shares lag Wall Street, ECB provides no momentum

* Wind turbine makers boosted by U.S. tax development (Adds closing prices, quotes)

topNews reuters.com

World shares little changed amid slate of central bank meetings

NEW YORK (Reuters) - World stock markets were little changed on Thursday after policy meetings from major central banks in Europe, while some U.S. shares were buoyed by news that the Republicans' tax legislation could face final votes in Congress before year-end.

companyNews reuters.com

GLOBAL MARKETS-World shares little changed amid slate of central bank meetings

* Dollar index up (Updates to U.S. trading open; changes byline, dateline, previously LONDON)

companyNews reuters.com

UPDATE 3-Bombardier's 2018 revenue forecast disappoints, shares fall

* Shares down 1.9 pct ahead of investor day at 3:00 p.m. ET (Adds analysts' estimate and comment, background and shares)

companyNews reuters.com

BRIEF-Medicure Acquires License To Sell Cardiovascular Drug In The U.S.

* MEDICURE ACQUIRES EXCLUSIVE LICENSE TO SELL AND MARKET BRANDED CARDIOVASCULAR DRUG IN THE U.S.

companyNews reuters.com

BRIEF-Casa Systems Sees IPO Of 6 Million Shares Of Its Common Stock Priced At $13 Per Share

* CASA SYSTEMS INC SEES IPO OF 6 MILLION SHARES OF ITS COMMON STOCK PRICED AT $13.00 PER SHARE - SEC FILING

worldNews reuters.com

Italy adopts living wills allowing patients to refuse treatment

ROME (Reuters) - Italy's Senate passed into law on Thursday a bill allowing severely ill people to refuse treatment that would prolong their lives.

companyNews reuters.com

BRIEF-Amicus Therapeutics Submits New Drug Application To U.S. FDA For Migalastat

* AMICUS THERAPEUTICS SUBMITS NEW DRUG APPLICATION TO U.S. FDA FOR MIGALASTAT FOR TREATMENT OF FABRY DISEASE

healthNews reuters.com

With no deal on children's health plan, U.S. states scramble for Plan B

NEW YORK/WASHINGTON (Reuters) - For Nancy Minoui of Portland, Oregon, and Crystal Lett of Dublin, Ohio, Congress' failure to fund the Children's Health Insurance Program is not some distant tale of political wrangling.

companyNews reuters.com

BRIEF-Protagonist Therapeutics Announces Final Phase 1 Study Results With Novel Hepcidin Mimetic, PTG-300

* PROTAGONIST THERAPEUTICS ANNOUNCES FINAL PHASE 1 STUDY RESULTS WITH NOVEL HEPCIDIN MIMETIC, PTG-300

healthNews reuters.com

Former Philippine President defends controversial dengue program

MANILA (Reuters) - Former Philippine President Benigno Aquino defended on Thursday his decision to implement a controversial immunization program using a new dengue vaccine in 2016, saying it was justified with millions of people at risk of being infected by the virus.

healthNews reuters.com

Treating bumps and humps: Dubai opens $10 million camel hospital

DUBAI (Reuters) - Pristine operating theaters and state-of-the-art medical equipment are featured in a new Dubai hospital that opened last week - exclusively for camels.

companyNews reuters.com

BRIEF-Glaxosmithkline Submits Regulatory Application For Single-Dose Tafenoquine For Treatment Of Plasmodium Vivax Malaria

* SUBMITS REGULATORY APPLICATION FOR SINGLE-DOSE TAFENOQUINE FOR TREATMENT OF PLASMODIUM VIVAX MALARIA TO AUSTRALIA'S THERAPEUTIC GOODS ADMINISTRATION​

companyNews reuters.com

UPDATE 1-Banks drag European shares down as investors await Draghi

* Wind turbine makers boosted by U.S. tax development (ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets)

cnn.com

Overall teen drug use low, but marijuana edging up

Teen drinking, smoking and drug use overall are stable, but the percentage of teens using marijuana is increasing, according to a new report from the University of Michigan's Institute for Social Research.

technologyNews reuters.com

Atos shares fall 2.8 percent after Gemalto rejects takeover bid

PARIS (Reuters) - Shares in Atos fell as much as 2.8 percent early on Thursday after Franco-Dutch chip maker Gemalto rejected its 4.3 billion euro ($5 billion) takeover bid.

companyNews reuters.com

UPDATE 1-Atos shares fall 2.8 pct after Gemalto rejects takeover bid

PARIS, Dec 14 (Reuters) - Shares in Atos fell as much as 2.8 percent early on Thursday after Franco-Dutch chip maker Gemalto rejected its 4.3 billion euro ($5 billion) takeover bid.

companyNews reuters.com

Atos shares fall 2.8 pct at open after Gemalto rejects takeover bid

PARIS, Dec 14 (Reuters) - Shares in Atos fell 2.8 percent early on Thursday after Franco-Dutch chip maker Gemalto rejected its takeover bid.

companyNews reuters.com

Banks drag European shares down as investors eye BoE, ECB meetings

LONDON, Dec 14 (Reuters) - Weakness in bank stocks dragged European shares to a downbeat open on Thursday as financial sectors caught the cold from U.S. and Asian trading which suffered from a less hawkish than expected tone from the U.S. Federal Reserve.

companyNews reuters.com

Nikkei slips, telecom shares slump on Rakuten market entry plan

TOKYO, Dec 14 (Reuters) - Japan's Nikkei share average slipped on Thursday, as banks and insurer shares weakened in line with lower interest rates while telecommunications shares withered on news that online retailer Rakuten plans to enter the mobile carrier market.

domesticNews reuters.com

U.S. executions edge up in 2017 but stay at decades' low: study

AUSTIN, Texas (Reuters) - U.S. executions and new death sentences rose slightly in 2017 from a year ago but remained the lowest in decades as capital punishment has declined in the country, a survey released on Thursday showed.

companyNews reuters.com

U.S. appeals court vacates conviction of drug distributor over Botox

Dec 13 (Reuters) - A U.S. appeals court on Wednesday vacated the conviction of the owner of a wholesale drug distributor accused of selling authentic Botox and other drugs with foreign labels, dealing another setback to the government, which has struggled at times to successfully prosecute similar such cases.

companyNews reuters.com

Nikkei edges down, telecom shares slump as Rakuten mulls market entry

TOKYO, Dec 14 (Reuters) - Japan's Nikkei share average erased earlier modest gains on Thursday to edge down, while telecommunications shares withered on news that online retailer Rakuten is weighing entry into the mobile carrier market.

companyNews reuters.com

BRIEF-Proteostasis Therapeutics Prices Public Offering Of 8 Mln Shares At $5/Share

* PROTEOSTASIS THERAPEUTICS PRICES PUBLIC OFFERING OF COMMON STOCK

companyNews reuters.com

Taiwan's Hon Hai Precision plans to list unit's shares in Shanghai

TAIPEI, Dec 14 (Reuters) - Taiwan's Hon Hai Precision Industry Co, the world's largest contract electronics manufacturer, said it planned to list shares of a subsidiary in Shanghai.

companyNews reuters.com

BRIEF-Boulevard Acquisition Says Institutional Investors Agreed To Private Placement Of New Estre Shares For About $130 Mln

* BOULEVARD ACQUISITION CORP. II AND ESTRE AMBIENTAL S.A. TRANSACTION UPDATE

healthNews reuters.com

Pfizer's second biosimilar of J&J's Remicade wins U.S. FDA approval

(Reuters) - The U.S. Food and Drug Administration approved Pfizer Inc's second biosimilar to Johnson & Johnson's blockbuster rheumatoid arthritis drug, Remicade, the company said on Wednesday.

healthNews reuters.com

Seasonal flu kills more globally than previously thought -U.S. study

CHICAGO (Reuters) - As many as 646,000 people are dying globally from seasonal influenza each year, U.S. health officials said on Wednesday, a rise from earlier assessments of the disease's death toll.

businessNews reuters.com

Bumper crop of new drugs fails to lift big pharma R&D returns

LONDON (Reuters) - It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice as many novel medicines as in 2016, yet returns on research investment at leading pharmaceutical companies are down.

healthNews reuters.com

Ohio passes law barring abortion over Down syndrome diagnosis

CLEVELAND (Reuters) - Women in Ohio would be prohibited from receiving abortions because of a fetal Down syndrome diagnosis under a bill that passed the state senate on Wednesday and is heading to Republican Governor John Kasich’s desk.

companyNews reuters.com

CORRECTED-BRIEF-Hines Global REIT II Makes Second Public Offering Of Up To $2.50 Bln In Shares Of Its Stock

Dec 12 (Reuters) - Hines Global Reit II: HINES GLOBAL REIT II SAYS MAKING A SECOND PUBLIC OFFERING OF UP TO $2.50 BILLION IN SHARES OF ITS STOCK- SEC FILING

companyNews reuters.com

U.S. study sheds light on how Zika causes nerve disorder

CHICAGO, Dec 13 (Reuters) - A new study sheds light on how the mosquito-borne Zika virus causes a rare neurological condition, and the findings could have implications for companies working on Zika vaccines, U.S. researchers said on Wednesday.

politicsNews reuters.com

Senator McCain treated for side effects of cancer therapy

WASHINGTON (Reuters) - U.S. Senator John McCain was undergoing treatment at a military hospital outside Washington for side effects of cancer therapy, his office said on Tuesday.

healthNews reuters.com

Head and neck cancer survivors have long-lasting cognitive problems

(Reuters Health) - Patients who survive head and neck cancer may be more likely to experience declines in cognitive function than people who don’t have these tumors, a recent study suggests.

companyNews reuters.com

BRIEF-Jetblue Airways says To Repurchase Up To $750 mln Shares

* AUTHORIZED TO REPURCHASE UP TO $750 MILLION OF SHARES OF STOCK OVER TWO YEARS, BEGINNING JAN 1 Source text : (http://bit.ly/2C2ucSq) Further company coverage:

cnn.com

Study: Climate change made Harvey's rainfall worse

Climate change is partly to blame for the record rainfall that fell over Texas and Louisiana in the days after Hurricane Harvey's landfall on August 25, according to new scientific analysis.

healthNews reuters.com

Fears of Israeli job cuts at Teva sparks call for general strike

TEL AVIV (Reuters) - Reports that Teva Pharmaceutical Industries is planning a restructuring involving mass layoffs in Israel sparked calls on Wednesday for a half-day general strike to be held in protest.

healthNews reuters.com

Shift work linked to burnout in sleep-deprived nurses

(Reuters Health) - Shift-work nurses who have sleep problems are more likely to experience career burnout that has the potential to compromise their job performance, a small Italian study suggests.

healthNews reuters.com

Music therapy may help ease depression

(Reuters Health) - Traditional depression treatments like psychotherapy or medication might work better for some patients when doctors add a dose of music therapy, a research review suggests.

healthNews reuters.com

Medtronic settles states' probe into Infuse marketing for $12 million

BOSTON (Reuters) - Medtronic Plc has agreed to pay $12 million to resolve claims that the company engaged in a deceptive marketing strategy to promote its Infuse bone graft product used in spinal surgery, the Massachusetts attorney general said on Wednesday.

healthNews reuters.com

Irish parliament committee backs referendum on abortion up to 12 weeks

DUBLIN (Reuters) - An Irish parliamentary committee on Wednesday recommended that an abortion referendum due next year should offer the choice of allowing terminations with no restrictions up to 12 weeks into a pregnancy, a more liberal position than some had anticipated.

healthNews reuters.com

Revance will wait to seek backing for Botox-rival

(Reuters) - Revance Therapeutics Inc will wait to seek partnerships with bigger drugmakers until it is closer to regulatory approval for its Botox rival treatment, Chief Executive Dan Browne told Reuters in an interview.

healthNews reuters.com

Obamacare sign-ups rise but overall enrollment set to fall

NEW YORK (Reuters) - The number of consumers who signed up for 2018 Obamacare health insurance surpassed the 1 million mark in the second-to-last week of enrollment, the government said on Wednesday, but it did not appear to be enough to grow the program.

healthNews reuters.com

Diabetes and obesity both tied to higher risk of cancer

(Reuters Health) - Many cancer cases worldwide may happen at least in part because people are overweight or have diabetes, a new report suggests.

healthNews reuters.com

Obamacare sign-ups rise to 1 million as pace picks up before deadline

NEW YORK (Reuters) - The number of consumers who signed up for 2018 Obamacare health insurance next year surpassed the 1 million mark in the second-to-last week of enrollment on the federally-run HealthCare.gov website, picking up the pace ahead of the Dec. 15 deadline.

healthNews reuters.com

Obamacare sign-ups gain steam as 2018 deadline nears

NEW YORK (Reuters) - More than 1.07 million consumers selected 2018 Obamacare individual insurance plans on the HealthCare.gov website during the week ended Dec. 9, the U.S. government reported on Wednesday, indicating a pick up in the pace of enrollment as the Dec. 15 deadline nears.

healthNews reuters.com

Doner kebabs survive EU lawmaker vote on additives

STRASBOURG (Reuters) - Doner kebab vendors across Europe won a victory in the European Parliament on Wednesday when European Union lawmakers failed to outlaw additives regularly used to preserve taste and moisture.

environmentNews reuters.com

Electronic waste at new high, squandering gold, other metals: study

OSLO (Reuters) - Electronic waste rose to a record 45 million tonnes worldwide in 2016, squandering valuable metals such as gold and copper since few trashed televisions, cellphones or other products get recycled, a U.N.-backed study showed on Wednesday.

healthNews reuters.com

Israel's Teva to cut jobs in restructuring on Thursday: report

TEL AVIV (Reuters) - Israel-based Teva Pharmaceutical Industries will unveil a restructuring plan on Thursday that will include laying off more than half its Israeli workforce, the Calcalist financial news website said.

companyNews reuters.com

UPDATE 2-Lilly's 2018 forecast beats on strength of new drugs

Dec 13 (Reuters) - Eli Lilly and Co on Wednesday forecast 2018 profit and revenue ahead of Wall Street estimates on strong demand for recently launched drugs such as Trulicity and Taltz.

healthNews reuters.com

Half of world's people can't get basic health services: WHO

LONDON (Reuters) - At least half the world's population is unable to access essential health services and many others are forced into extreme poverty by having to pay for healthcare they cannot afford, the World Health Organization said on Wednesday.

healthNews reuters.com

Aurora Cannabis wins rights for licensing talks with CannaRoyalty

(Reuters) - Canadian medical marijuana maker Aurora Cannabis Inc has won the rights to negotiate a licensing deal with CannaRoyalty Corp that will allow it to sell a range of cannabis-infused consumer products.

companyNews reuters.com

BRIEF-South Atlantic Bancshares To Acquire Atlantic Bancshares

* SOUTH ATLANTIC BANCSHARES, INC. TO ACQUIRE ATLANTIC BANCSHARES, INC.

businessNews reuters.com

Shares eye record high as Fed heads for 2017 hat-trick

LONDON (Reuters) - Global shares were within a whisker of another record high on Wednesday as markets traded on expectations of a third U.S. interest rate hike this year and waited to hear from the Federal Reserve on how many more are likely in 2018.

healthNews reuters.com

Philippines' Duterte says dengue campaign carried out in 'good faith'

MANILA (Reuters) - President Rodrigo Duterte believes the previous Philippine government acted in good faith in launching an immunization drive that used a new dengue vaccine on hundreds of thousands of children, he said on Wednesday.

businessNews reuters.com

Shares eye record high as Fed heads for hat-trick

LONDON (Reuters) - Global shares were within a whisker of another record high on Wednesday as markets traded on expectations of a third U.S. interest rate hike of the year, and waited to hear from the Federal Reserve how many more are likely in 2018.

cnn.com

Tour de France champion failed drug test

Chris Froome, who has been the world's most dominant cyclist in recent years, failed a drugs test in one of cycling's most prestigious races earlier this year.

companyNews reuters.com

GLOBAL MARKETS-Shares eye record high as Fed heads for hat-trick

LONDON, Dec 13 (Reuters) - Global shares were within a whisker of another record high on Wednesday as markets traded on expectations of a third U.S. interest rate hike of the year, and waited to hear from the Federal Reserve how many more are likely in 2018.

healthNews reuters.com

France's Sanofi pins hopes on new drugs after setbacks

PARIS (Reuters) - French pharmaceuticals group Sanofi said on Wednesday it had suffered from low uptake for a new cholesterol drug and from concerns about a dengue vaccine, but expressed confidence its pipeline of new products would support long-term growth.

companyNews reuters.com

UPDATE 2-France's Sanofi pins hopes on new drugs after setbacks

* CEO says company on track to sell European generics unit (Adds details, shares)

sportsNews reuters.com

Cycling: Froome tested positive for asthma drug during Vuelta

LONDON (Reuters) - Four-time Tour de France winner Chris Froome failed a urine test at the Vuelta a Espana in September but the Briton said on Wednesday he had done nothing wrong.

companyNews reuters.com

UPDATE 1-European shares open on a cautious note ahead of Fed meeting

* Telecom Italia dips, CEO meets gvt (Adds more stocks, context)

companyNews reuters.com

European shares open on a cautious note ahead of Fed meeting

LONDON, Dec 13 (Reuters) - European bourses opened on a cautious note on Wednesday despite gains on Wall Street and in Asia as investors await a U.S. Federal reserve meeting and assess the political implications of Donald Trump's setback in a bitter Senate election in Alabama.

healthNews reuters.com

Sanofi sees nine regulatory submissions over next 18 months

PARIS (Reuters) - Sanofi said on Wednesday it expected to file nine regulatory submissions for new drugs over the next 18 months and that its pipeline of new products would support long-term growth.

healthNews reuters.com

Teva Pharm to unveil restructuring plan on Thursday: report

TEL AVIV (Reuters) - Israel-based Teva Pharmaceutical Industries will unveil a restructuring plan on Thursday that will include layoffs, the Calcalist financial news website said on Wednesday.

businessNews reuters.com

Asian shares up, dollar dips as Republicans lose Alabama Senate race

TOKYO (Reuters) - U.S. stock futures, Treasury yields and the dollar dipped on Wednesday as Democrat Doug Jones beat Republican Roy Moore in a bitter U.S. Senate race in Alabama, while Asian shares gained as crude oil futures took back some lost ground.

companyNews reuters.com

GLOBAL MARKETS-Asian shares up, dollar dips as Republicans lose Alabama Senate race

TOKYO, Dec 13 (Reuters) - U.S. stock futures, Treasury yields and the dollar dipped on Wednesday as Democrat Doug Jones beat Republican Roy Moore in a bitter U.S. Senate race in Alabama, while Asian shares gained as crude oil futures took back some lost ground.

companyNews reuters.com

Nikkei dented by weaker tech shares; Shikoku Electric stumbles

TOKYO, Dec 13 (Reuters) - Japan's Nikkei share average ended lower on Wednesday after tech stocks lost ground as they tracked their weaker U.S. counterparts, while Shikoku Electric slumped after a court ruled against the restart of one of its nuclear reactors.

businessNews reuters.com

Asian shares up, dollar dips as Democrat wins Alabama Senate race

TOKYO (Reuters) - U.S. stock futures, Treasury yields and the dollar fell on Wednesday as Democrat Doug Jones beat Republican Roy Moore in a bitter U.S. Senate race in Alabama, while Asian shares edged up as crude oil futures took back lost ground.

companyNews reuters.com

GLOBAL MARKETS-Asian shares up, dollar dips as Democrat wins Alabama Senate race

* Democrat seen beating Trump-backed candidate in Senate race

companyNews reuters.com

BRIEF-Blueprint Medicines Prices Public Offering Of 3.70 Mln Shares At $81.00/Share

* BLUEPRINT MEDICINES ANNOUNCES PRICING OF PUBLIC OFFERING OF SHARES OF COMMON STOCK

healthNews reuters.com

Did Sanofi, WHO ignore warning signals on dengue vaccine?

CHICAGO/LONDON (Reuters) - When French drugmaker Sanofi published the results of clinical trials of children given its dengue vaccine two years ago, the overall findings were that it protected against the world's biggest and fastest growing mosquito-borne disease.

companyNews reuters.com

Nikkei edges lower as weaker tech shares offset boost from financials

TOKYO, Dec 13 (Reuters) - Japan's Nikkei share average edged lower on Wednesday morning after tech stocks lost ground as they tracked their weaker U.S. counterparts, offsetting gains in the financial space.

companyNews reuters.com

BRIEF-Bluebird Bio Prices Public Offering Of 3.2 Mln Shares At $185/Share

* BLUEBIRD BIO ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

businessNews reuters.com

Asian shares flat, Fed hike expectations underpin dollar

TOKYO (Reuters) - Asian shares were treading water in early trade on Wednesday as crude oil futures steadied after a selloff, while a widely expected interest rate hike from the Federal Reserve underpinned the dollar.

companyNews reuters.com

GLOBAL MARKETS-Asian shares flat, Fed hike expectations underpin dollar

TOKYO, Dec 13 (Reuters) - Asian shares were treading water in early trade on Wednesday as crude oil futures steadied after a selloff, while a widely expected interest rate hike from the Federal Reserve underpinned the dollar.

companyNews reuters.com

BRIEF-Iron Mountain Says Public Offering Of 14.5 Mln Common Shares Priced At $37 Per Share

* SAYS PUBLIC OFFERING OF 14.5 MILLION COMMON SHARES PRICED AT $37.00PER SHARE Source text for Eikon: Further company coverage:

companyNews reuters.com

BRIEF-‍Alimentation Couche-Tard Founder Alain Bouchard To Sell Shares

* ALIMENTATION COUCHE-TARD- ALAIN BOUCHARD HAS INFORMED CORPORATION OF HIS INTENTION TO SELL 200,000 CLASS B SUBORDINATED VOTING SHARES THAT HE HOLDS​

healthNews reuters.com

U.S. judge questions Trump administration on birth control rules

OAKLAND, Calif. (Reuters) - A U.S. judge questioned on Tuesday whether the federal government properly formulated new rules that undermine an Obamacare requirement for employers to provide insurance that covers women's birth control.

companyNews reuters.com

BRIEF-Heartland Financial USA Announces Plan To Acquire First Bank Lubbock Bancshares In Texas

* HEARTLAND FINANCIAL USA, INC. ANNOUNCES PLAN TO ACQUIRE FIRST BANK LUBBOCK BANCSHARES, INC. IN TEXAS

healthNews reuters.com

Republicans propose to delay, pause Obamacare taxes

WASHINGTON (Reuters) - U.S. House Republicans proposed on Tuesday to delay or suspend several taxes under former President Barack Obama's healthcare law, including a tax on medical devices and the so-called "Cadillac" tax on generous health insurance plans.

companyNews reuters.com

BRIEF-Hines Global Makes Second Public Offering Of Up To $2.50 Bln In Shares Of Its Stock

* HINES GLOBAL REIT SAYS MAKING A SECOND PUBLIC OFFERING OF UP TO $2.50 BILLION IN SHARES OF ITS STOCK- SEC FILING Source text: [http://bit.ly/2AeIqiE] Further company coverage:

healthNews reuters.com

Many young U.S. men at high risk for HIV do not take anti-HIV pill

(Reuters Health) - Less than 4 percent of young adult men-who-have-sex-with-men in the U.S. – a population at significant risk of contracting the human immunodeficiency virus (HIV) – reported ever using the pill that protects them from the virus, in a recently published study.

healthNews reuters.com

Older women should not take hormones to prevent chronic diseases

(Reuters Health) - Postmenopausal women should not use hormone therapy to prevent chronic medical conditions, because the risk of significant side effects outweighs the unclear evidence of a benefit, according to a government-backed panel of experts.

companyNews reuters.com

UPDATE 2-Shares in Brazilian homebuilder MRV shoot up with ambitious growth plan

SAO PAULO, Dec 12 (Reuters) - Shares in Brazilian homebuilder MRV Engenharia e Participações SA shot up more than 5 percent on Tuesday as executives unveiled plans to start construction on 50,000 new home units in 2018, which could generate more than 7 billion reais ($2.1 billion) in sales.

healthNews reuters.com

Hearing loss may be a risk factor for dementia

(Reuters Health) - Older adults who develop hearing loss may more likely to experience dementia and cognitive decline than their counterparts without hearing problems, a research review suggests.

companyNews reuters.com

BRIEF-Vertex, CRISPR Therapeutics To Co-Develop CTX001 As CRISPR/Cas9 Gene Edited Treatment

* VERTEX AND CRISPR THERAPEUTICS TO CO-DEVELOP AND CO-COMMERCIALIZE CTX001 AS CRISPR/CAS9 GENE EDITED TREATMENT FOR SICKLE CELL DISEASE AND Î’-THALASSEMIA

politicsNews reuters.com

House Speaker Ryan says he believes upbeat Treasury tax study

WASHINGTON (Reuters) - U.S. House Speaker Paul Ryan on Tuesday defended a one-page analysis by the Treasury Department that asserted a tax plan pushed by the Republican-led Congress would pay for itself in 10 years.

healthNews reuters.com

Motorcycle passengers have higher head injury risks

Reuters Health - Motorcycle passengers are less likely than drivers to wear helmets, and they are more likely to suffer traumatic brain injuries in crashes, a U.S. study suggests.

cnn.com

Anchor shares post-brain surgery video

Six months after undergoing brain surgery, former co-anchor of "E! News" Maria Menounos shares a video taken 24 hours after the life-saving procedure.

healthNews reuters.com

'Heat-not-burn' tobacco may be safer but still a risk: UK panel

LONDON (Reuters) - A new wave of "heat-not-burn" tobacco products are probably safer than traditional cigarettes but the devices still produce a number of potentially harmful compounds, some of which are carcinogenic, a British panel of experts said on Tuesday.

healthNews reuters.com

EU health and food safety experts warn of stubborn salmonella

LONDON (Reuters) - The number of salmonella food poisoning cases in the European Union has risen by 3 percent since 2014 in a "worrying" reversal of a decade-long declining trend, EU health and food safety officials said on Tuesday.

businessNews reuters.com

Sanofi investors hungry for drug progress and deal news

PARIS (Reuters) - Sanofi still needs to convince markets it can deliver on an exciting and sustainable growth path as it contends with fresh difficulties in its vaccines arm and looks set for another gloomy year in diabetes, investors told Reuters.

companyNews reuters.com

BRIEF-Tapimmune Announces Enrollment Of First Patient In Phase 2 Clinical Trial For Treating Triple-Negative Breast Cancer

* TAPIMMUNE ANNOUNCES ENROLLMENT OF FIRST PATIENT IN PHASE 2 CLINICAL TRIAL FOR TREATING TRIPLE-NEGATIVE BREAST CANCER FUNDED BY U.S. DEPARTMENT OF DEFENSE

healthNews reuters.com

Cholera resurges in Zambian capital Lusaka, WHO says

GENEVA (Reuters) - Cholera has killed 15 people and made 547 sick in Zambia's capital Lusaka and the rising caseload is expected to grow further as the rainy season starts, according to the World Health Organization.

Colleges and Universities nytimes.com

Contributing Op-Ed Writer: Chinese and Studying in America

The determination and perseverance that have made Chinese students winners at home can deepen their sense of frustration abroad.

Brazil nytimes.com

Brazil Fights H.I.V. Spike in Youths With Free Preventive Drug

The country is the first in Latin America to make a blue pill called PrEP an integral part of its health care policy.

environmentNews reuters.com

Study seen needed before lifting fracking ban in remote Australia

SYDNEY (Reuters) - Gas extraction via fracking could only resume in Australia's Northern Territory district after a study on the controversial practice is completed in two to three years, according to the recommendations of an independent group released on Tuesday.

companyNews reuters.com

U.S. FDA accepts application for Indivior's new schizophrenia drug

Dec 12 (Reuters) - U.S. Food and Drug Administration (FDA) accepted Indivior's application for its new schizophrenia treatment, the British drugmaker said on Tuesday, boosting hopes of marketing the drug in the country.

companyNews reuters.com

BRIEF-‍Altice Nv Altice Intends To Reduce Its Share Capital By Cancelling Treasury Shares​

* On June 28, 2017, the general meeting of Altice N.V. granted authority to the Board to cancel common shares A and common shares B in the share capital of the company held by the company.

businessNews reuters.com

Asia shares take a time out, Brent breaks above $65

SYDNEY (Reuters) - Asian shares took a small step back on Tuesday after three straight sessions of gains, with markets consolidating in the hope an upswing in global growth could outlast a likely hike in U.S. borrowing costs this week.

companyNews reuters.com

GLOBAL MARKETS-Asia shares take a time out, Brent breaks above $65

* Brent crude tops $65 a barrel for first time since mid-2015

businessNews reuters.com

Asia shares take breather, Brent breaks above $65

SYDNEY (Reuters) - Asian shares took a breather on Tuesday after three straight sessions of gains, with markets consolidating in the hope an upswing in global growth could outlast a likely hike in U.S. borrowing costs this week.

companyNews reuters.com

GLOBAL MARKETS-Asia shares take breather, Brent breaks above $65

* Brent crude tops $65 a barrel for first time since mid-2015

healthNews reuters.com

NZ's Fisher & Paykel sues Resmed in Australia over patent dispute

(Reuters) - New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents.

companyNews reuters.com

BRIEF-Trico Bancshares Enters San Francisco Bay Area With Acquisition Of FNB Bancorp

* ENTERS SAN FRANCISCO BAY AREA WITH ACQUISITION OF FNB BANCORP

cnn.com

Having older brothers increases men's likelihood of being gay, study says

If you're a guy with an older brother, there's an increased chance you're gay.

healthNews reuters.com

Air pollution fine particles linked to poor sperm quality

(Reuters Health) - Exposure to fine particles in air pollution may be another factor that affects men’s sperm quality and their fertility, suggest researchers in Taiwan.

healthNews reuters.com

Retirement linked to longer, better sleep

(Reuters Health) – As work worries abate, sleep difficulties may also diminish when workers make the transition to retirement, according to a recent study from Finland.

companyNews reuters.com

BRIEF-Bookrunner Says Detsky Mir Final Deal Size Expected To Be 46.5mm Shares in accelerated bookbuilt offering

* BLOCK TRADE - DETSKY MIR: BOOKRUNNER SAYS TRANSACTION EXPECTED TO PRICE AT RUB 90 PER SHARE; FINAL DEAL SIZE EXPECTED TO BE 46.5MM SHARES AT THIS PRICE‍​ Further company coverage:

companyNews reuters.com

BRIEF-Agios Pharmaceuticals Presents New Safety Data From Study on Leukemia Drug

* PRESENTS NEW SAFETY DATA FROM PHASE 1 EXPANSION STUDY EVALUATING ORAL IVOSIDENIB IN PATIENTS WITH R/R AML AND IDH1 MUTATION

healthNews reuters.com

Amgen's Kyprolis improves overall survival in blood cancer patients

(Reuters) - Amgen Inc said on Monday new data from a late-stage trial testing Kyprolis in combination with two other drugs showed improved overall survival rate in patients with blood cancer.

politicsNews reuters.com

U.S. Treasury tax study slammed as 'fake math' by Democrats

WASHINGTON (Reuters) - The U.S. Treasury Department on Monday released a one-page analysis of the economic and fiscal impact of a Republican tax overhaul plan that was swiftly criticized by a number of tax experts and attacked as "fake math" by Democrats.

healthNews reuters.com

Promising responses seen with Agios leukemia drug in study

(Reuters) - Nearly a third of patients with an advanced form of a fast-progressing leukemia who carry a specific genetic mutation experienced a complete or near complete response to an experimental Agios Pharmaceuticals drug, according to data from an early stage trial released on Monday.

healthNews reuters.com

Breast reconstruction after cancer less common at cash-strapped hospitals

(Reuters Health) - Women with breast cancer who have one or both breasts removed are less likely to get immediate reconstruction surgery at hospitals that are struggling financially, a U.S. study suggests.

healthNews reuters.com

Commuters often exposed to damaging noise levels

(Reuters Health) - Loud noise exceeding levels that can damage hearing is regularly encountered by commuters using buses, subways and even biking, a Canadian study suggests.

healthNews reuters.com

Kids continue to die in window-blind accidents, despite safety warnings

(Reuters Health) - Even though window coverings have been recognized for decades as a safety hazard to children, injuries from blinds and shades still send many kids to the emergency room each year, a U.S. study suggests.

healthNews reuters.com

FDA OKs Sanofi's follow-on biologic of Lilly's diabetes drug Humalog

(Reuters) - The U.S. Food and Drug Administration said on Monday it approved Sanofi SA's Admelog as the first follow-on biologic version of Eli Lilly and Co's fast-acting insulin, Humalog.

healthNews reuters.com

Austria to drop impending smoking ban, bucking Western trend

VIENNA (Reuters) - While much of the West has barred smoking in restaurants and bars, Austria's impending ban is set to be stubbed out.

cnn.com

Drug trial shows promising results to fight Huntington's disease

For the first time, an experimental drug has reduced levels of the toxic protein that causes Huntington's disease in humans.

healthNews reuters.com

Opioid painkiller prescriptions may run in families

Reuters Health - When one person in a household gets prescribed opioids, the other people who live with them are more likely to get their own prescriptions for these narcotic painkillers, a U.S. study suggests.

worldNews reuters.com

Iran will treat jailed aid worker as Iranian citizen-foreign ministry

BEIRUT (Reuters) - Iran will treat a British-Iranian aid worker as an Iranian citizen and she will serve her sentence as determined by the judiciary, Iran's foreign ministry spokesman said on Monday.

healthNews reuters.com

'Ground-breaking' new drug gives hope in Huntington's disease

LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntington's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.

companyNews reuters.com

UPDATE 1-'Ground-breaking' new drug gives hope in Huntington's disease

LONDON, Dec 11 (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntington's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.

companyNews reuters.com

BRIEF-Anthera Pharmaceuticals Announces Positive Outcome In The Phase 3 Result Clinical Study Of Sollpura

* ANTHERA PHARMACEUTICALS ANNOUNCES POSITIVE OUTCOME OF INTERIM FUTILITY ANALYSIS IN THE PHASE 3 RESULT CLINICAL STUDY OF SOLLPURA

healthNews reuters.com

'Ground-breaking' new drug gives hope on Huntingdon's disease

LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntingdon's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.

companyNews reuters.com

BRIEF-Suning Commerce sells 5.5 mln shares in Alibaba, expects net income of 3.25 bln yuan

* SAYS IT EXPECTS NET INCOME OF 3.25 BILLION YUAN ($491.16 million) AFTER SELLING 5.5 MILLION SHARES IN ALIBABA GROUP HOLDING Source text in Chinese: http://bit.ly/2B32uI0 Further company coverage: ($1 = 6.6170 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Children and Childhood nytimes.com

The Checkup: Treating Anxiety in Children

Which child needs psychotherapy or medication: the parent-clinger, the dog-fearer or the school-avoider?

companyNews reuters.com

BRIEF-Affimed presents data from Phase 1B combination study of AFM13 with pembrolizumab at Ash

* Affimed presents data from Phase 1B combination study of AFM13 with Pembrolizumab at Ash

healthNews reuters.com

Indonesia races to contain diphtheria outbreak ahead of 2018 Asian Games

JAKARTA (Reuters) - Health authorities in Jakarta kicked off a special immunization program on Monday to rein in an "extraordinary" outbreak of diphtheria that has sparked concerns about the Indonesian capital’s readiness to host the Asian Games next June. Diphtheria cases have spiked 42 percent since last year, health officials say, with at least 32 deaths and more than 590 cases recorded across the archipelago, the bulk of them in densely populated Jakarta and neighboring provinces.

healthNews reuters.com

GSK's new pharma head on lookout for cancer deals to boost pipeline

LONDON (Reuters) - GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its presence in oncology, its new head of pharmaceuticals told Reuters.

healthNews reuters.com

Roche: Tecentriq cocktail slows kidney cancer progression

ZURICH (Reuters) - Combining Roche's Tecentriq immunotherapy with its older drug Avastin reduced the risk of disease worsening or death (PFS) for the initial treatment of advanced kidney cancer in some patients, the Swiss drugmaker said on Monday

businessNews reuters.com

Bitcoin futures rocket past $18,000; Asian shares buoyant

SYDNEY (Reuters) - The craze for cryptocurrencies entered a new chapter on Monday as bitcoin futures rocketed by one-fifth of their value at a hotly anticipated launch, while Asian shares climbed amid optimism about global growth.

companyNews reuters.com

GLOBAL MARKETS-Bitcoin futures rocket past $18,000; Asian shares buoyant

* Fed expected to hike rates this week; BoE, ECB also meeting

healthNews reuters.com

Merck raises stakes in lung cancer as rivals close in

LOS ANGELES (Reuters) - Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer.

businessNews reuters.com

Bitcoin futures surge past $18,000; Asian shares firm

SYDNEY (Reuters) - The craze for cryptocurrencies entered a new chapter on Monday as bitcoin futures rocketed by one-fifth of their value at a closely-watched launch, while Asian shares climbed amid optimism about global growth.

companyNews reuters.com

GLOBAL MARKETS-Bitcoin futures surge past $18,000; Asian shares firm

* Fed expected to hike rates this week; BoE, ECB also meeting

sportsNews reuters.com

Ice hockey brothers first bans after NZ drug probe

WELLINGTON (Reuters) - Two brothers who played ice hockey for New Zealand have become the first athletes to be banned after an investigation into the sale of performance-enhancing drugs to amateur sportspeople in the country.

companyNews reuters.com

UPDATE 1-Novartis CAR-T therapy leads to durable response in lymphoma study

Dec 10 (Reuters) - Patients with an advanced form of an aggressive blood cancer who had initially responded to Novartis' new type of gene-modifying immunotherapy continued to respond at least six months after treatment, according to updated data released at a medical meeting on Sunday.

companyNews reuters.com

BRIEF-‍Verastem Announces Clinical Data From Pivotal Phase 3 Duo Study​

* ‍VERASTEM ANNOUNCES CLINICAL DATA FROM PIVOTAL PHASE 3 DUO™ STUDY​

healthNews reuters.com

Hospital operators in merger talks to form U.S. industry leader: WSJ

NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in talks about a merger between the two Catholic non-profits that would create the largest U.S. hospital chain, the Wall Street Journal reported on Sunday, citing people familiar with the discussions.

healthNews reuters.com

Hospital operators in merger talks to create U.S. industry leader: WSJ

NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in discussions about a merger that would create the largest hospital chain in the United States, the Wall Street Journal reported on Sunday, citing people familiar with the situation.

healthNews reuters.com

Exclusive: Philippines defied experts' advice in pursuing dengue immunization program

MANILA (Reuters) - As she announced in January 2016 that the Philippines would immunize one million children with a new dengue vaccine, the nation's then health secretary Janette Garin boasted it was a world-first and a tribute to her country's "expertise" in research.

healthNews reuters.com

France orders international recall of Lactalis baby formula

PARIS (Reuters) - France has ordered banned the sale and ordered a recall of several baby formula milk and baby food products made by French dairy giant Lactalis after the discovery of salmonella bacteria, consumer protection agency DGCCRF said in a statement.

healthNews reuters.com

Gilead's new drug keeps 56 percent of lymphoma trial patients alive

(Reuters) - More than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a novel therapy sold by Gilead Sciences Inc, according to study results presented on Sunday.

companyNews reuters.com

Gilead's new drug keeps 56 pct of lymphoma trial patients alive

Dec 10 (Reuters) - More than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a novel therapy sold by Gilead Sciences Inc, according to study results presented on Sunday.

companyNews reuters.com

'Unheard of' responses to bluebird CAR-T therapy seen in myeloma study

Dec 10 (Reuters) - More than half of patients with advanced multiple myeloma who had run out of therapeutic options remained in complete remission after receiving bluebird bio Inc's experimental gene-modifying immunotherapy in a small, early stage study, according to updated data released on Sunday.

companyNews reuters.com

Novartis CAR-T therapy leads to durable response in lymphoma study

Dec 10 (Reuters) - Patients with an advanced form of an aggressive blood cancer who had initially responded to Novartis' new type of gene-modifying immunotherapy continued to respond at least six months after treatment, according to updated data released at a medical meeting on Sunday.

healthNews reuters.com

Roche lymphoma drug drives high remission rate, longer survival: study

(Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.

companyNews reuters.com

Roche lymphoma drug drives high remission rate, longer survival-study

Dec 10 (Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.

worldNews reuters.com

Nobel peace laureate group urges nuclear powers to adopt ban-the-bomb treaty

OSLO (Reuters) - The leader of the group that won this year's Nobel Peace Prize on Sunday urged nuclear nations to adopt a United Nations treaty banning atomic weapons in order to prevent "the end of us".

Politics and Government nytimes.com

Macron Steps Into Middle East Role as U.S. Retreats

President Emmanuel Macron of France is carving out an ambitious and assertive global role, as many see the United States under President Trump abandoning leadership.

Drugs (Pharmaceuticals) nytimes.com

Prescription Drugs May Cost More With Insurance Than Without It

Some consumers are finding they can get a better deal on prescription drugs by leaving their insurance cards at home.

worldNews reuters.com

Russia fully compliant nuclear missile treaty: deputy foreign minister

MOSCOW (Reuters) - Russia is fully committed to the 1987 Intermediate-Range Nuclear Forces Treaty and plans to continue complying with it, Deputy Foreign Minister Sergei Ryabkov said on Saturday.

companyNews reuters.com

Drug industry group sues to stop California drug price law

Dec 8 (Reuters) - The trade group representing U.S. drugmakers on Friday said it has a filed a lawsuit to stop California from implementing a law aimed at reining in prescription drug prices.

healthNews reuters.com

U.S. House committee 'may reconsider' WHO cancer agency funds

LONDON (Reuters) - U.S. congressional committee members warned on Friday that Washington's funding of the World Health Organization's cancer research agency could be halted unless it is more open about its operations.

healthNews reuters.com

Lilly's stomach cancer drug meets main goal, but fails to improve survival rate

(Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a gastric cancer treatment met the main goal of preventing the disease from advancing, but failed its secondary target of improving overall survival rates.

companyNews reuters.com

UPDATE 1-Lilly's stomach cancer drug meets main goal, but fails to improve survival rate

Dec 8 (Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a gastric cancer treatment met the main goal of preventing the disease from advancing, but failed its secondary target of improving overall survival rates.

companyNews reuters.com

REFILE-Lilly's Cyramza meets main goal in gastric cancer study

Dec 8 (Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a treatment for a type of gastric cancer met its main goal of preventing the disease from advancing.

companyNews reuters.com

BRIEF-Leap Therapeutics Files For Resale Of Up To 3.73 Mln Shares Of Co's Common Stock By Selling Stockholders

* LEAP THERAPEUTICS INC FILES FOR RESALE OF UP TO 3.73 MILLION SHARES OF CO'S COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING Source text: (http://bit.ly/2jdjIfs) Further company coverage:

companyNews reuters.com

BRIEF-Skyline Medical Files For Resale Of Up To 1.9 Mln Shares By Selling Stockholder

* SKYLINE MEDICAL INC FILES FOR RESALE OF UP TO 1.9 MILLION SHARES OF CO'S COMMON STOCK BY THE SELLING STOCKHOLDER - SEC FILING Source text: (http://bit.ly/2BQ55m2) Further company coverage:

companyNews reuters.com

BRIEF-Lilly's Cyramza meets Primary Endpoint in gastric cancer study

* LILLY REPORTS TOP-LINE RESULTS FROM CYRAMZA® (RAMUCIRUMAB) PHASE 3 STUDY IN FIRST-LINE ADVANCED GASTRIC CANCER

healthNews reuters.com

Lilly's Cyramza meets main goal in gastric cancer study

(Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a treatment for a type of gastric cancer met its main goal of preventing the disease from advancing.

healthNews reuters.com

Depression in late teens linked to high school drop out

(Reuters Health) - Older teens struggling with depression are more than twice as likely to drop out of high school as peers without that mental illness or those who recovered from a bout of depression earlier in life, Canadian researchers say.

healthNews reuters.com

Kids who get moving may also get better grades

(Reuters Health) - Students who get extra physical activity may pay more attention in school and do better in subjects like reading and math, a research review suggests.

healthNews reuters.com

Acupressure app may help ease menstrual cramp pain

(Reuters Health) - Women with intense menstrual cramp pain may get more relief from smartphone app-guided acupressure than with typical medical treatments like painkillers, a recent study suggests.

companyNews reuters.com

BRIEF-Lombard Odier Asset Management Owns About 9.85% Issued & Outstanding Ordinary Shares Of Horizonte Minerals As At Dec 8

* LOMBARD ODIER ASSET MANAGEMENT - AS AT DEC 8, CO HAS OWNERSHIP OF ABOUT 9.85% OF ISSUED & OUTSTANDING ORDINARY SHARES OF HORIZONTE MINERALS Source text for Eikon: Further company coverage:

cnn.com

Vets use unconventional therapy to treat PTSD

As a Marine serving in the Iraq War, Sgt. Andrew Manzi spent long hours on patrol, never knowing what dangers were ahead.

healthNews reuters.com

Credibility, recipes, references help food blogs improve eating habits

(Reuters Health) - Consumers like healthy eating blogs written by nutritionists who seem credible and who interact with their readers, a small study in Canada suggests.

companyNews reuters.com

BRIEF-KKR Has Brought Its Tender Offer For Shares Of Hitachi Kokusai Electric To A Close - Nikkei‍​

* KOHLBERG KRAVIS ROBERTS HAS BROUGHT ITS TENDER OFFER FOR SHARES OF HITACHI KOKUSAI ELECTRIC TO A CLOSE - NIKKEI‍​

businessNews reuters.com

Steinhoff shares climb off 14-year low in volatile trade

JOHANNESBURG (Reuters) - Steinhoff shares plunged another 50 percent on Friday, before paring some losses as traders booked profits on short positions taken out after the South African retailer disclosed accounting irregularities earlier this week.

worldNews reuters.com

U.S. presses Russia to comply with nuclear missile treaty

WASHINGTON (Reuters) - The United States is reviewing military options, including new intermediate-range cruise missile systems, in response to what it says is Russia's ongoing violation of a Cold War-era pact banning such missiles, the State Department said on Friday.

healthNews reuters.com

Uganda says it has contained an outbreak of Marburg hemorrhagic fever

KAMPALA (Reuters) - Uganda said on Friday it had successfully contained an outbreak of the Marburg virus, a highly infectious haemorrhagic fever announced by officials on Oct. 19, which killed three people.

worldNews reuters.com

U.S. says it will take steps to press Russia to comply with INF nuclear treaty

WASHINGTON (Reuters) - The United States warned on Friday that the Intermediate-Range Nuclear Forces Treaty is under threat because of Russian cruise missile activity and Washington will pursue diplomatic, economic and military steps to encourage Moscow to return to compliance.

companyNews reuters.com

BRIEF-Aevi Genomic Medicine Files For Resale Of Up To 26.2 Mln Shares Of Co's Common Stock By Selling Stockholders

* AEVI GENOMIC MEDICINE INC FILES FOR RESALE OF UP TO 26.2 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING Source text - http://bit.ly/2kEddlX Further company coverage:

healthNews reuters.com

Pfizer breast cancer drug superior to chemotherapy in late stage study

(Reuters) - Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday.

companyNews reuters.com

Pfizer breast cancer drug superior to chemotherapy in Phase III study

Dec 8 (Reuters) - Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday.

healthNews reuters.com

Top Russian pork producer Miratorg reports ASF outbreak

MOSCOW (Reuters) - Russia's largest pork producer Miratorg on Friday reported an outbreak of African Swine Fever (ASF) at one of its sites in the Belgorod region in central Russia.

sportsNews reuters.com

Peru's Guerrero to miss World Cup after drugs ban

(Reuters) - Peru's hopes at next year's World Cup finals were dealt a huge blow when captain and all-time record goalscorer Paolo Guerrero was banned for one year on Friday after failing an anti-doping test for cocaine.

businessNews reuters.com

Steinhoff shares bounce off 14-year low in volatile trade

JOHANNESBURG (Reuters) - Steinhoff shares plunged another 50 percent on Friday, before recovering as traders booked profits on short positions taken out after the South African retailer disclosed accounting irregularities earlier this week.

healthNews reuters.com

Venezuela's chronic shortages give rise to 'medical flea markets'

SAN CRISTOBAL/MARACAIBO, Venezuela (Reuters) - Venezuela's critical medicine shortage has spurred "medical flea markets," where peddlers offer everything from antibiotics to contraceptives laid out among the traditional fruits and vegetables.

healthNews reuters.com

Russia's meat firm Miratorg reports ASF outbreak at 1 site in Russia

MOSCOW (Reuters) - Russian privately-owned meat producer Miratorg said on Friday there was an outbreak of African Swine Fever (ASF) at one of its sites in Russia's Belgorod region.

sportsNews reuters.com

FIFA bans Peru skipper Guerrero for one year for drug offence

ZURICH (Reuters) - FIFA's disciplinary committee has banned Peruvian soccer captain Paulo Guerrero for one year after he failed a doping test, the watchdog said on Friday.